Fidelity Investments
DTIL icon

Fidelity Investments’s Precision BioSciences DTIL Stock Holding History

Fidelity Investments’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$417 Buy
+53
New +$373 ﹤0.01% 5328
2025
Q2 		– Sell
-100
Closed -$477 – 5365
2025
Q1 		$477 Sell
100
-600
-86% -$3.05K ﹤0.01% 5024
2024
Q4 		$2.67K Buy
700
+575
+460% +$4.2K ﹤0.01% 4765
2024
Q3 		$1.12K Buy
+125
New +$1.2K ﹤0.01% 4891
2024
Q2 		– Sell
-2
Closed -$27 – 5425
2024
Q1 		$27 Buy
+2
New +$24 ﹤0.01% 5134
2023
Q3 		– Sell
-1,124
Closed -$17.7K – 5335
2023
Q2 		$17.7K Buy
1,124
+981
+686% +$22.4K ﹤0.01% 3916
2023
Q1 		$3.24K Sell
143
-30
-17% -$989 ﹤0.01% 4503
2022
Q4 		$6.18K Buy
+173
New +$6.84K ﹤0.01% 4183
2022
Q3 		– Sell
-2,237
Closed -$107K – 4968
2022
Q2 		$107K Buy
2,237
+137
+7% +$8.04K ﹤0.01% 3307
2022
Q1 		$194K Buy
+2,100
New +$285K ﹤0.01% 3260
2021
Q4 		– Sell
-2
Closed -$1K – 4455
2021
Q3 		$1K Sell
2
-9,196
-100% -$3.12M ﹤0.01% 4120
2021
Q2 		$3.46M Sell
9,198
-17,928
-66% -$5.38M ﹤0.01% 2423
2021
Q1 		$8.42M Sell
27,126
-9,789
-27% -$3.43M ﹤0.01% 2092
2020
Q4 		$9.24M Sell
36,915
-3,771
-9% -$924K ﹤0.01% 1999
2020
Q3 		$7.52M Hold
40,686
– – ﹤0.01% 1927
2020
Q2 		$10.2M Sell
40,686
-40,687
-50% -$8.91M ﹤0.01% 1805
2020
Q1 		$14.7M Sell
81,373
-6,298
-7% -$1.65M ﹤0.01% 1540
2019
Q4 		$36.5M Sell
87,671
-36,937
-30% -$11.6M ﹤0.01% 1352
2019
Q3 		$31.4M Hold
124,608
– – ﹤0.01% 1388
2019
Q2 		$49.5M Hold
124,608
– – 0.01% 1222
2019
Q1 		$67.1M Buy
+124,608
New +$66.1M 0.01% 1083

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Fidelity Investments's DTIL Position: Q2 2026 in Review

Fidelity Investments opened a new position in Precision BioSciences (DTIL) in Q2 2026: 53 shares worth $417. The stake represents ﹤0.01% of the portfolio and ranks #5328 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in DTIL as recently as Q1 2025.

Fidelity Investments first reported a position in DTIL in Q1 2019 and has held it in 21 quarters since. The position peaked at $67.1M in Q1 2019. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Fidelity Investments held 53 shares of Precision BioSciences worth $417 as of Q2 2026.
  • Precision BioSciences was a new Fidelity Investments position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5328 holding.
  • Fidelity Investments first reported a position in Precision BioSciences in Q1 2019 and has held it in 21 quarters since.
  • Fidelity Investments's Precision BioSciences position peaked at $67.1M in Q1 2019.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.